Fundraising Fox

Jason Gehrke

Investor

Entrepreneur-in-Residence at Third Rock Ventures

West Coast

About

Jason Gehrke joined Third Rock Ventures as an Entrepreneur-in-Residence in 2024, focusing on building immunology and genetic medicine companies. He previously held research leadership roles at Beam Therapeutics, including the BEAM-201 program, and holds a PhD in gene editing from Harvard.

Invests in

Biotech

Experience

  1. Third Rock VenturesEntrepreneur in Residencecurrent2024 β€” present
  2. Beam TherapeuticsVP, Immunology, Genetic Disease, and New Opportunities2023 β€” 2024
  3. Beam TherapeuticsSenior Director and Head of Immunology2022 β€” 2023
  4. Beam TherapeuticsDirector and Head of Immunology2021 β€” 2022
  5. Beam Therapeutics Inc.Senior Scientist, Head of New Opportunities2019 β€” 2020
  6. Beam Therapeutics Inc.Scientist and Head of New Opportunities2018 β€” 2020
  7. Beam Therapeutics Inc.Scientist2018 β€” 2019

Skills & more

ResearchMolecular Biology4Cell CultureData AnalysisBiochemistryPCRScience3Western BlottingCell BiologyStatisticsProtein Purification1

From Jason's professional profile.

Colleagues at Third Rock Ventures

Frequently asked questions

Who is Jason Gehrke?
Jason Gehrke joined Third Rock Ventures as an Entrepreneur-in-Residence in 2024, focusing on building immunology and genetic medicine companies. He previously held research leadership roles at Beam Therapeutics, including the BEAM-201 program, and holds a PhD in gene editing from Harvard.
Where does Jason Gehrke work?
Jason Gehrke is Entrepreneur-in-Residence at Third Rock Ventures.
What does Jason Gehrke invest in?
Jason Gehrke invests in Biotech.
Where did Jason Gehrke go to school?
Jason Gehrke studied at UCLA (BS, Molecular); Harvard University (Doctor of Philosophy - PhD, Biochemistry and Molecular Biology).

Same school

Shared employers